Laboratorio Reig Jofre SA Share Price Cinnober Boat
Stocks
0RB1
ES0165359029
Pharmaceuticals
| Market Cap | 215M 0 250M 202M 184M 345M 23.77B 346M 2.4B 927M 12.11B 938M 918M 38.36B | P/E 2026 * |
13.2x | P/E 2027 * | 22x |
|---|---|---|---|---|---|
| Enterprise Value | 300M 0 348M 282M 257M 481M 33.13B 483M 3.34B 1.29B 16.88B 1.31B 1.28B 53.48B | EV / Sales 2026 * |
0.82x | EV / Sales 2027 * | 0.75x |
| Free-Float |
20.57% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Laboratorio Reig Jofre SA
| 1 day | +2.41% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 31/12/2005 | |
Laura Martí
DFI | Director of Finance/CFO | - | 19/12/2023 |
Carmen Esclapés
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/12/2014 | |
| Director/Board Member | 58 | 30/12/2014 | |
| Director/Board Member | - | 06/11/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.41% | -.--% | - | - | 253M | |
| +0.03% | -3.09% | +49.77% | +91.69% | 1,002B | |
| -0.76% | -2.95% | +50.93% | +66.34% | 649B | |
| +0.86% | -4.13% | +19.24% | +68.37% | 440B | |
| -0.80% | -0.43% | +28.92% | +35.45% | 346B | |
| -0.13% | -14.97% | +9.41% | +26.71% | 263B | |
| -1.90% | -2.72% | -2.72% | +7.41% | 250B | |
| -0.48% | -11.65% | +39.75% | +50.82% | 213B | |
| -1.06% | -4.23% | -14.70% | -57.36% | 201B | |
| -0.68% | -2.65% | +25.82% | +91.64% | 182B | |
| Average | -0.27% | -4.42% | +22.94% | +42.34% | 393.74B | |
| Weighted average by Cap. | -0.42% | -3.88% | +31.98% | +57.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 365M 0 424M 344M 313M 586M 40.35B 588M 4.07B 1.57B 20.56B 1.59B 1.56B 65.13B | 392M 0 455M 369M 336M 629M 43.34B 632M 4.37B 1.69B 22.08B 1.71B 1.67B 69.94B |
| Net income | 16.7M 0 19.41M 15.72M 14.33M 26.81M 1.85B 26.91M 186M 72.03M 941M 72.87M 71.29M 2.98B | 9.5M 0 11.04M 8.95M 8.15M 15.25M 1.05B 15.31M 106M 40.97M 535M 41.46M 40.55M 1.7B |
| Net Debt | 84.7M 0 98.43M 79.75M 72.67M 136M 9.37B 137M 945M 365M 4.77B 370M 362M 15.12B | 78.7M 0 91.46M 74.1M 67.52M 126M 8.7B 127M 878M 339M 4.43B 343M 336M 14.05B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
